Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ATOMOXETINE Cause Therapeutic product effect incomplete? 285 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 285 reports of Therapeutic product effect incomplete have been filed in association with ATOMOXETINE (Atomoxetine). This represents 3.1% of all adverse event reports for ATOMOXETINE.

285
Reports of Therapeutic product effect incomplete with ATOMOXETINE
3.1%
of all ATOMOXETINE reports
271
Deaths
245
Hospitalizations

How Dangerous Is Therapeutic product effect incomplete From ATOMOXETINE?

Of the 285 reports, 271 (95.1%) resulted in death, 245 (86.0%) required hospitalization, and 245 (86.0%) were considered life-threatening.

Is Therapeutic product effect incomplete Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ATOMOXETINE. However, 285 reports have been filed with the FAERS database.

What Other Side Effects Does ATOMOXETINE Cause?

Drug ineffective (1,352) Off label use (1,132) Nausea (889) Vomiting (820) Fatigue (786) Abdominal pain upper (755) Headache (741) Dizziness (720) Pain (705) Insomnia (695)

What Other Drugs Cause Therapeutic product effect incomplete?

ALBUTEROL (8,496) ADALIMUMAB (6,986) PREDNISONE (6,709) METHOTREXATE (6,037) TOFACITINIB (4,914) SECUKINUMAB (4,661) BUDESONIDE\FORMOTEROL (4,392) TIOTROPIUM (4,327) MEPOLIZUMAB (4,106) ETANERCEPT (3,961)

Which ATOMOXETINE Alternatives Have Lower Therapeutic product effect incomplete Risk?

ATOMOXETINE vs ATOMOXETINE\ATOMOXETINE ATOMOXETINE vs ATORVASTATIN ATOMOXETINE vs ATORVASTATIN\EZETIMIBE ATOMOXETINE vs ATOSIBAN ATOMOXETINE vs ATOVAQUONE

Related Pages

ATOMOXETINE Full Profile All Therapeutic product effect incomplete Reports All Drugs Causing Therapeutic product effect incomplete ATOMOXETINE Demographics